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Figure S4
Dotted line denotes mitochondrial targeting sequence Green box denotes catalytic cysteine Red box denotes amino acid mutated in the common human ALDH2 polymorphism (E487K, Aldh2*2) responsible for the 'Asian Flush'
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Supplemental Experimental Procedures
Flow cytometry
Flow cytometry was performed on bone marrow, spleen and thymic cells that were isolated from mutant mice and appropriate controls. Bone marrow cells were obtained either by flushing from the femora and tibiae (adult bones) or by crushing the femora, tibiae and humeri (P1 pups) and passing through a 40-µm filter. The following antibodies were used to stain for the Lin -cKit + Sca1 + population of the bone marrow: FITC-conjugated lineage cocktail with antibodies anti-CD4 (clone H129.19, BD Pharmingen), CD3e (clone 145-2C11, eBioscience), Ly-6G/Gr-1 (clone RB6-8C5, eBioscience), CD11b/Mac-1 (clone M1/70, BD Pharmingen), CD45R/B220 (clone RA3-6B2, BD Pharmingen), Fcε R1α (clone MAR-1, eBioscience), CD8a
(clone 53-6.7, BD Pharmingen), CD11c (clone N418, eBioscience) and TER-119 (clone Ter119, BD Pharmingen) and anti-c-Kit (PerCP-Cy5.5, clone 2B8, eBioscience) and Sca-1 (PE-Cy7, clone D7, eBioscience) antibodies. B and T cells in the spleen were assessed using anti-CD45R/B220 (APC, clone RA3-6B2, BD Pharmingen), CD3e (PerCPCy5.5, clone 145-2C11, eBioscience), CD4 (FITC, clone H129.19, BD Pharmingen) and CD8a (PE, clone 53-6.7, BD Pharmingen) antibodies.
The maturation of the erythroid lineage in the spleen was analysed using antibodies anti-TER-119 (FITC, clone Ter-119, BD Pharmingen) and anti-CD71 (APC, clone C2, BD Pharmingen). Thymic T-cells were assessed using a PE-conjugated lineage cocktail with antibodies anti-Ly-6G/Gr-1 (clone RB6-8C5, eBioscience), CD11b/Mac-1 (clone M1/70, BD Pharmingen), CD45R/B220 (clone RA3-6B2, BD Pharmingen), CD11c (clone N418, eBioscience), CD3e (clone 145-2C11, eBioscience) and TER-119 (clone Ter119, BD Pharmingen), and anti-CD4 (BV421, clone H129.19, BD Pharmingen) and CD8a (APC, clone 53-6.7, BD Pharmingen) antibodies. All antibodies were used at 1:200 and the samples were incubated for 15 min at 4 °C in the dark. Samples were run on a LSRII flow cytometer (BD Pharmingen) and the data were analysed with FlowJo 10.0.7 (Tree Star).
Aldehyde dehydrogenase activity assay
Mouse livers, whole E13.5 embryos or placentas (0.5 g) were finely minced with scissors and homogenised with 500 µl of homogenisation buffer (210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 5 mM MOPS pH 7.4 in H 2 0) using a tight-fitting Dounce homogeniser. The homogenate was centrifuged at 700 x g for 10 min, the supernatant removed, and centrifuged again at 700 x g for 10 min. The supernatant was removed and centrifuged at 7000 x g for 20 min. The pellet was washed in homogenisation buffer and centrifuged again at 7000 x g for 10 min. The pellet was re-suspended in 300 µl of enzyme assay buffer (10 mM DTT, 20 % glycerol, 0.1 % Triton X-100 and 0.1 M Tris-HCl pH 8.0 in H 2 0) and centrifuged at 100,000 x g for 30 min at 4 °C to obtain a clear supernatant. Protein concentration was measured using a NanoDrop. To perform the Aldh enzymatic activity assay, a 2 ml reaction was setup in a cuvette containing 50 mM NaPPi buffer pH 9.0, 2.5 mM NAD + , 10 mM acetaldehyde and 0.5 mg protein preparation in H 2 0. The absorbance at 340 nm was recorded using a Cary 5000 UV-Vis-NIR spectrophotometer, at room temperature (RT) for 300 s without the addition of the acetaldehyde substrate, in order to quench the reaction of endogenous aldehydes. After 3 min, the acetaldehyde was added, and the absorbance at 340 nm was recorded for a further 350 s. To calculate the [NADH] production in mols/min/mg total protein, we used: Absorbance = ε x c x L, where ε = 6220 M -1 , L = path length (1 cm) and c = [NADH] in mols. The assay was adapted from a protocol by D Mochley-Rosen, Stanford University.
Survival assays of primary mouse B cells
The primary mouse B cells survival assay was performed with lymphocytes purified from the spleen using Lympholyte M (Cederlane). Lymphocytes were stimulated with LPS (Sigma L4391) at a final concentration of 40 µg ml −1 . A total of 4 × 10 5 cells were plated with acetaldehyde at various concentrations in one well of a 24-well plate. After 7 days, the total cells were enumerated, counting 100 images using a ViCell XR (Beckman Coulter). Each data point represents the mean of two independent experiments, each carried out in quadruplicate.
Methylcellulose c.f.u.-GM survival assay
The methylcellulose c.f.u.-GM survival assay was carried out as described previously (Meagher et al., 1982) . Briefly, total bone marrow was flushed in IMDM (GIBCO) from the femora and tibiae of mice. Equal numbers of total bone marrow cells were exposed to various concentrations of acetaldehyde in vitro for 4 h in a sealed CryoVial. After treatment, two ten-fold serial dilutions of the bone marrow were made, and these cells were plated in duplicate into 6-well plates with methylcellulose medium with recombinant cytokines (without EPO; MethoCult™ GF M3534).
Colonies were counted after 7 days.
